Allogene Therapeutics, Inc.·4

Feb 14, 5:10 PM ET

Bhavnagri Veer 4

4 · Allogene Therapeutics, Inc. · Filed Feb 14, 2023

Insider Transaction Report

Form 4
Period: 2023-02-13
Bhavnagri Veer
General Counsel
Transactions
  • Sale

    Common Stock

    2023-02-13$6.85/sh3,000$20,550577,677 total
Footnotes (1)
  • [F1]1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT